Exosome-Derived miRNAs as Potential Biomarkers for Prostate Bone Metastasis
Zhenquan Lu,Jian Hou,Xiao Li,Jun Zhou,Bingfeng Luo,Songwu Liang,Richard K Lo,Tak Man Wong,Guan-Ming Kuang,Richard Lo
DOI: https://doi.org/10.2147/IJGM.S361981
IF: 2.145
2022-06-02
International Journal of General Medicine
Abstract:Zhenquan Lu, 1, &ast Jian Hou, 1, &ast Xiao Li, 2 Jun Zhou, 2 Bingfeng Luo, 1 Songwu Liang, 1 Richard K Lo, 1 Tak Man Wong, 2 Guan-Ming Kuang 2 1 Department of Urology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong Province, People's Republic of China; 2 Department of Orthopaedics and Traumatology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Guan-Ming Kuang, Email Purpose: The purpose of this study was to identify the potential exosome-derived microRNAs (miRNAs) related to prostate cancer (Pca) bone metastasis. Methods: Two datasets were collected. One dataset was from the authors' institute, for which two groups of 10 patients each were designed: in the first one, the patients had early-stage localised Pca without bone metastasis, and in the other, the patients presented with Pca with bone metastasis. Then, the miRNA expression profiles of the blood exosomes were obtained and analysed. The other dataset was a public dataset of the miRNA expression transcriptome (GSE26964), which was downloaded from Gene Expression Omnibus (GEO). The results of both datasets were jointly analysed and the most bone-metastatic-related differentially expressed miRNAs (diff-miRNAs) were identified and further validated. Finally, a series of bioinformatics analyses were performed and the relationship between target genes of the diff-miRNAs and the pathogenesis and progression of bone metastasis of Pca were studied. Results: From the authors' dataset, in all, 313 diff-miRNAs were identified, of which 205 were up-regulated while 108 were down-regulated. From the GSE26964 dataset, 107 diff-miRNAs were found, of which 44 were up-regulated and 63 were down-regulated. Taking the intersection of the results of both datasets, four diff-miRNAs were identified: hsa-miR-125a-3p, hsa-miR-330-3p, hsa-miR-339-5p and hsa-miR-613. In all, 94 target genes of the four diff-miRNAs were predicted. After considering the intersection of the results from the GSE32269 dataset, we obtained 25 target genes. Although either positive or negative correlations were found among the diff-miRNAs with some of the target genes, there is a lack of evidence on how such correlations regulate the development and promotion of Pca bone metastasis. Conclusion: Hsa-miR-125a-3p, hsa-miR-330-3p, hsa-miR-339-5p and hsa-miR-613 are potential biomarkers for Pca bone metastasis. Keywords: prostate cancer, bone metastasis, exosomes, bioinformatics analysis, miRNAs Prostate cancer (Pca) is considered the most common malignant tumour in the male urological system. 1 Approximately 90% of late-stage Pca patients present with bone metastasis. Pca patients with bone metastasis may have severe pain in the back and/or the extremities, leading to significant disabilities in daily activities (eg, difficulties in standing, walking and changing postures) and, consequently, patients are mainly wheelchair or bed bound. Furthermore, associated complications, such as urinary tract infection, pulmonary infection and deep vein thrombosis, may occur. As a result, the quality of life is significantly decreased, and the mortality rate is increased. However, we currently have a limited understanding of the underlying mechanism of Pca developing bone metastasis. Thus, we are unable to establish better strategies to prevent Pca from bone metastasis and to improve the life expectancy of late-stage Pca patients. Recently, studies have shown that tumour cells release exosomes, 2–5 which are small membrane vesicles (30–150 nm) that contain complex RNAs and proteins. 6 Furthermore, miRNAs are non-coding small RNA molecules that bind to the 3'-untranslated region of the target mRNAs to regulate and alter the expression of the target genes. These miRNAs are transferred between cells via exosomes, which act as a communication tool between cells and thus modify the microenvironment in which tumour cells metastasise. 7,8 Li et al 9 found that miR-375 was overexpressed in exosomes derived from metastatic PCa cells. Duan et al 10 found that PC-3-derived exosomes inhibited NF-κB signalling pathway activity by down-regulating the miR-214 expression, thereby inhibiting osteoclast differentiation and thus achieving the attenuation of PCa bone metastasis. Therefore, bone metastasis in PCa can be considered to be related to the interaction between tumour cells and the skeletal microenvironment, in which the miRNAs in the exosomes may play an important regulatory role as sign -Abstract Truncated-
medicine, general & internal